Big Money Sentiment decreased to 0.72 in 2017 Q4. It has change of 0.16, from 2017Q3s 0.88. The ratio worsened due to CVS Health Corporation positioning: 115 sold and 600 reduced. 134 funds amassed positions and 380 increased positions. Investors holded 801.45 million in 2017Q3 but now own 815.59 million shares or 1.76% more.
Truepoint Incorporated, Ohio-based fund reported 43,512 shs. Baystate Wealth Mngmt Limited Liability Company has 0.02% invested in CVS Health Corporation (NYSE:CVS). Atlantic Trust Group Ltd Company stated it has 1.35M shs or 0.42% of all its holdings. Brinker Inc invested in 0.25% or 90,042 shs. Amica Mutual Insurance owns 40,344 shs. Lord Abbett And Ltd stated it has 0.32% in CVS Health Corporation (NYSE:CVS). Vanguard Grp has invested 0.25% in CVS Health Corporation (NYSE:CVS). Legacy Private holds 42,094 shs. Waddell & Reed Finance holds 0.12% or 732,969 shs. Birch Hill Invest Advsr Limited Co accumulated 46,821 shs. Advsrs Limited Co holds 16,038 shs or 0.08% of its capital. Whitnell holds 1.46% or 48,158 shs in its capital. Alps Advisors holds 6,275 shs or 0% of its capital. Bright Rock Cap Mngmt Ltd Liability Co holds 2.18% or 111,000 shs in its capital. Yhb Advisors invested in 90,500 shs or 1.12% of the stock.
CVS Health Corporation had 1 insider sale and 0 insider buys since February 16, 2018. Thiss net activity of $1.42 million.
CVS Health Corporation (NYSE:CVS)s earnings release is anticipated by WallStreet on May, 1, RTT reports. The EPS diference is $0.23 or 19.66 % up from last years number. Previous year: $1.17; Analysts forcast: $1.40. If $1.40 is reported, CVSs profit will hit $1.42B for 11.33 P/E. After $1.92 EPS report last quarter, Wall Street now predicts -27.08 % negative EPS growth of CVS Health Corporation. The stock decreased 0.89% or $0.57 during the last trading session, reaching $63.43.Currently CVS Health Corporation is downtrending after 22.81% change in last April 15, 2017. CVS has also 5.83 million shares volume. The stock underperformed the S&P 500 by 34.36%.
CVS Health Corporation (NYSE:CVS) Ratings Coverage
Total analysts of 14 have positions in CVS Health (NYSE:CVS) as follows: 10 rated it a Buy, 0 with Sell and 4 with Hold. The positive are 71%. Since October 18, 2017 according to StockzIntelligence Inc CVS Health has 30 analyst reports. On Thursday, January 4 SunTrust maintained CVS Health Corporation (NYSE:CVS) with Buy rating. On Thursday, February 8 RBC Capital Markets maintained CVS Health Corporation (NYSE:CVS) rating. RBC Capital Markets has Buy rating and $89.0 target. In Tuesday, November 21 report Leerink Swann maintained the stock with Buy rating. In Tuesday, November 7 report Loop Capital maintained the stock with Hold rating. In Tuesday, January 2 report Needham maintained the stock with Buy rating. On Tuesday, November 7 Jefferies maintained CVS Health Corporation (NYSE:CVS) rating. Jefferies has Hold rating and $76 target. On Tuesday, December 26 the stock has Buy rating by Tigress Financial. On Friday, October 27 the stock has Hold rating by Robert W. Baird. On Monday, December 4 the stock of CVS Health Corporation (NYSE:CVS) has Buy rating given by Needham. On Thursday, January 4 Robert W. Baird maintained the shares of CVS in report with Hold rating.
CVS Health Corporation, together with its subsidiaries, provides integrated pharmacy health care services.The firm is worth $64.41 billion. It operates through Pharmacy Services and Retail/LTC divisions.The P/E ratio is 9.85. The Pharmacy Services segment offers pharmacy benefit management solutions, such as plan design and administration, formulary management, Medicare Part D services, mail order, specialty pharmacy and infusion services, retail pharmacy network management services, prescription management systems, clinical services, disease management programs, and medical pharmacy management services.